Biohaven starts life as new company following Pfizer buyout

Oct 5, 2022 · Now, the team behind that company is attempting to find similar success a second time. On Tuesday, Biohaven Ltd. officially launched as a newly independent company, spun …

CouponFollow Extension

$12
OFF

Here's What's Next For Biohaven After Its $12 Billion Pfizer Buyout ...

1 week from now

Feb 2, 2023 · Biohaven (BHVN) is following the same strategy with its remaining drug pipeline as it did prior to Pfizer 's (PFE) massive buyout of the bulk of its assets — and BHVN stock has …

investors.com

$148.50
OFF

Pfizer Completes Acquisition Of Biohaven Pharmaceuticals

1 week from now

Oct 3, 2022 · Pfizer acquired all of the outstanding shares of Biohaven not already owned by Pfizer for $148.50 per share in cash, for a total transaction consideration of approximately …

pfizer.com

$11
OFF

Pfizer Completes Acquisition Of Biohaven Pharmaceuticals

1 week from now

Oct 4, 2022 · Pfizer has completed its acquisition of Biohaven Pharmaceuticals for approximately $11.6 billion. Pfizer announced on Oct. 3, 2022 that it has completed its acquisition of …

biopharminternational.com

$13
OFF

Two Years After Selling Its Migraine Assets To Pfizer In $13B Deal, …

1 week from now

Oct 28, 2024 · The purchase also included about 1,000 Biohaven workers becoming Pfizer employees, leaving the New Haven company with about 300 people on staff mostly doing …

hartfordbusiness.com

$11
OFF

Pfizer To Acquire Biohaven In $11.6B Bet On Biotech's Migraine Drugs

1 week from now

May 10, 2022 · Pfizer has agreed to acquire Biohaven Pharmaceuticals for $11.6 billion in a deal that turns an existing alliance on a fast-selling migraine drug into a big bet on its future growth. …

biopharmadive.com

$11
OFF

Pfizer To Pay $11.6 Bln For Biohaven To Tap Migraine Market

1 week from now

Show more companies. May 10 (Reuters) - Pfizer Inc (PFE.N) said on Tuesday it will pay $11.6 billion to buy Biohaven Pharmaceutical Holding Co (BHVN.N), making a big bet on its ability to …

reuters.com

$2.97
OFF

Biohaven (BHVN) Up On PFE's Buyout Offer, Q1 Loss Wider

1 week from now

May 11, 2022 · In a separate press release, Biohaven also reported first-quarter 2022 results. BHVN incurred a loss of $2.97 per share for first-quarter 2022, wider than the Zacks …

nasdaq.com

$12
OFF

Biohaven Sends Latest Drug To FDA, Despite Past Trial Setback

1 week from now

May 31, 2023 · Dive Insight: The current version of Biohaven was spun out following the company’s acquisition by Pfizer in a near-$12 billion deal last year. The pharmaceutical …

biopharmadive.com

$11
OFF

Pfizer To Buy Biotech Group Biohaven For $11.6bn - Financial Times

1 week from now

May 10, 2022 · Pfizer has agreed to buy US biotech Biohaven Pharmaceuticals for $11.6bn, striking its biggest deal in more than five years as the pharma company bolsters its pipeline of …

ft.com

$11
OFF

Pfizer To Buy Biohaven Pharmaceutical In $11.6 Bln Deal

1 week from now

May 10 (Reuters) - Pfizer Inc PFE.N said on Tuesday it will buy migraine drug maker Biohaven Pharmaceutical Holding Company Ltd BHVN.N for about $11.6 billion in cash. Pfizer will …

nasdaq.com